164 related articles for article (PubMed ID: 7495984)
41. Proteinases, cell cycle regulation, and apoptosis during mammary gland involution (minireview).
Wiesen J; Werb Z
Mol Reprod Dev; 2000 Aug; 56(4):534-40. PubMed ID: 10911404
[No Abstract] [Full Text] [Related]
42. Akt1 ablation inhibits, whereas Akt2 ablation accelerates, the development of mammary adenocarcinomas in mouse mammary tumor virus (MMTV)-ErbB2/neu and MMTV-polyoma middle T transgenic mice.
Maroulakou IG; Oemler W; Naber SP; Tsichlis PN
Cancer Res; 2007 Jan; 67(1):167-77. PubMed ID: 17210696
[TBL] [Abstract][Full Text] [Related]
43. The SV40 small t-antigen prevents mammary gland differentiation and induces breast cancer formation in transgenic mice; truncated large T-antigen molecules harboring the intact p53 and pRb binding region do not have this effect.
Goetz F; Tzeng YJ; Guhl E; Merker J; Graessmann M; Graessmann A
Oncogene; 2001 Apr; 20(18):2325-32. PubMed ID: 11402328
[TBL] [Abstract][Full Text] [Related]
44. Mammary carcinogenesis in transgenic mice expressing a dominant-negative mutant of DNA polymerase beta in their mammary glands.
Wang L; Bhattacharyya N; Rabi T; Wang L; Banerjee S
Carcinogenesis; 2007 Jun; 28(6):1356-63. PubMed ID: 17166880
[TBL] [Abstract][Full Text] [Related]
45. The role of the microenvironment in mammary gland development and cancer.
Polyak K; Kalluri R
Cold Spring Harb Perspect Biol; 2010 Nov; 2(11):a003244. PubMed ID: 20591988
[TBL] [Abstract][Full Text] [Related]
46. HBX causes cyclin D1 overexpression and development of breast cancer in transgenic animals that are heterozygous for p53.
Klein A; Guhl E; Tzeng YJ; Fuhrhop J; Levrero M; Graessmann M; Graessmann A
Oncogene; 2003 May; 22(19):2910-9. PubMed ID: 12771941
[TBL] [Abstract][Full Text] [Related]
47. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
Zhang H; Stephens LC; Kumar R
Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
[TBL] [Abstract][Full Text] [Related]
48. Matrix metalloproteinases and their expression in mammary gland.
Uria JA; Werb Z
Cell Res; 1998 Sep; 8(3):187-94. PubMed ID: 9791732
[TBL] [Abstract][Full Text] [Related]
49. Sustained trophism of the mammary gland is sufficient to accelerate and synchronize development of ErbB2/Neu-induced tumors.
Landis MD; Seachrist DD; Abdul-Karim FW; Keri RA
Oncogene; 2006 Jun; 25(23):3325-34. PubMed ID: 16434967
[TBL] [Abstract][Full Text] [Related]
50. [Unexpected functions of a matrix metalloproteinase, stromelysin 3].
Mathelin C; Rio MC
Bull Cancer; 2004 Feb; 91(2):125. PubMed ID: 15047448
[No Abstract] [Full Text] [Related]
51. Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instability.
McCormack SJ; Weaver Z; Deming S; Natarajan G; Torri J; Johnson MD; Liyanage M; Ried T; Dickson RB
Oncogene; 1998 May; 16(21):2755-66. PubMed ID: 9652742
[TBL] [Abstract][Full Text] [Related]
52. Transgenic mice with mammary gland targeted expression of human cortactin do not develop (pre-malignant) breast tumors: studies in MMTV-cortactin and MMTV-cortactin/-cyclin D1 bitransgenic mice.
van Rossum AG; van Bragt MP; Schuuring-Scholtes E; van der Ploeg JC; van Krieken JH; Kluin PM; Schuuring E
BMC Cancer; 2006 Mar; 6():58. PubMed ID: 16536875
[TBL] [Abstract][Full Text] [Related]
53. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P
Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418
[TBL] [Abstract][Full Text] [Related]
54. Overexpression of the colony-stimulating factor (CSF-1) and/or its receptor c-fms in mammary glands of transgenic mice results in hyperplasia and tumor formation.
Kirma N; Luthra R; Jones J; Liu YG; Nair HB; Mandava U; Tekmal RR
Cancer Res; 2004 Jun; 64(12):4162-70. PubMed ID: 15205327
[TBL] [Abstract][Full Text] [Related]
55. Rassf3 is responsible in part for resistance to mammary tumor development in neu transgenic mice.
Jacquemart IC; Springs AE; Chen WY
Int J Oncol; 2009 Feb; 34(2):517-28. PubMed ID: 19148488
[TBL] [Abstract][Full Text] [Related]
56. Expression pattern of four membrane-type matrix metalloproteinases in the normal and diseased mouse mammary gland.
Szabova L; Yamada SS; Birkedal-Hansen H; Holmbeck K
J Cell Physiol; 2005 Oct; 205(1):123-32. PubMed ID: 15895410
[TBL] [Abstract][Full Text] [Related]
57. Role of F-box protein betaTrcp1 in mammary gland development and tumorigenesis.
Kudo Y; Guardavaccaro D; Santamaria PG; Koyama-Nasu R; Latres E; Bronson R; Yamasaki L; Pagano M
Mol Cell Biol; 2004 Sep; 24(18):8184-94. PubMed ID: 15340078
[TBL] [Abstract][Full Text] [Related]
58. Stromelysin in tumor progression and metastasis.
McDonnell S; Matrisian LM
Cancer Metastasis Rev; 1990 Dec; 9(4):305-19. PubMed ID: 2097083
[TBL] [Abstract][Full Text] [Related]
59. The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis.
Sternlicht MD; Lochter A; Sympson CJ; Huey B; Rougier JP; Gray JW; Pinkel D; Bissell MJ; Werb Z
Cell; 1999 Jul; 98(2):137-46. PubMed ID: 10428026
[TBL] [Abstract][Full Text] [Related]
60. In situ force mapping of mammary gland transformation.
Lopez JI; Kang I; You WK; McDonald DM; Weaver VM
Integr Biol (Camb); 2011 Sep; 3(9):910-21. PubMed ID: 21842067
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
